Schedule 13G ownership disclosure

KARYOPHARM THERAPEUTICS INC

Security class unavailable · CUSIP: 48576U106

Event date: 2017-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,043,735
Percent of class
12.8100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-18-000141
Form type
SC 13G/A
Filer
Karyopharm Therapeutics Inc.
CIK
CIK 1503802
Filed
Feb 08, 2018
Reporting period
Dec 29, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub